Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation
The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Introduction We have recently shown that fluoxetine, a serotonin-specific reuptake inhibitor (SSRI), has low micromolar affinity for the 5-HT(2C) receptor (but not for 5-HT(2A) and 5-HT(2B) receptors) in primary cultures of mouse astrocytes. This was determined as phosphorylation (stimulation) of extracellular-regulated kinase 1 and 2 (ERK(1/2)) by transactivation-mediated phosphorylation of the epidermal growth factor (EGF) receptor, followed by conventional EGF receptor signaling (Li et al., Psychopharmacology 194:333-334, 2007). Paroxetine has an identical effect. The present study shows that chronic fluoxetine treatment with even higher affinity (EC(50) = 0.5-2.0 microM) upregulates Ca(2+)-dependent phospholipase A(2) (cPLA(2)), which releases arachidonic acid from the sn-2 position of membrane-bound phospholipid, without effect on secretory PLA(2) (sPLA(2)) and intracellular PLA(2) (iPLA(2)). Discussion This demonstration replicates the fluoxetine-induced cPLA(2) upregulation in rat brain shown by Rao et al. (Pharmacogenomics J 6:413-420, 2006) and provides the new information that upregulation (1) occurs in astrocytes, (2) is evoked by stimulation of 5-HT(2B) receptor, and (3) requires transactivation-mediated ERK(1/2) phosphorylation. Similar upregulation of cPLA(2) in intact brain in response to 5-HT(2)-mediated signaling by elevated serotonin levels and/or an SSRI during antidepressant treatment may explain the repeatedly reported ability of SSRIs to normalize region…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The GSK3β polymorphisms are associated with the high risk of MDD in Chinese Han Population. 61”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [61]
Citations
Cites
1 retracted
Rao, J. S., Ertley, R. N., Lee, H.-J., Rapoport, S. I., & Bazinet, R. P. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500391 · Cited by 41
RetractedBradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“The protein content was determined in the homogenates by the Bradford method ( Bradford, 1976 ), using bovine serum albumin as the standard.”
MethodIdentification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,015
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
(1972) · Springer eBooks · doi:10.1007/978-1-4615-7172-8 · Cited by 1,370
Astrocyte Control of Synaptic Transmission and Neurovascular Coupling
Haydon, P. G., & Carmignoto, G. (2006) · Physiological Reviews · doi:10.1152/physrev.00049.2005 · Cited by 1,323 · cited 1×
“Release of arachidonic acid from astrocytes is stimulated by adenosine triphosphate (Strokin et al. 2003), a "gliotransmitter" ( Haydon and Carmignoto 2006 ), and may exert both autocrine and paracrine effects.”
BackgroundMayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01036-2 · Cited by 1,115
Rothman, R. B., Baumann, M. H., Savage, J. E., Rauser, L., McBride, A., Hufeisen, S. J., & Roth, B. L. (2000) · Circulation · doi:10.1161/01.cir.102.23.2836 · Cited by 722 · cited 1×
“The two concentrations of fluoxetine (1 and 10 µM) used in this study are slightly higher and lower, respectively, than the Ki values found for fluoxetine and its primary metabolite, norfluoxetine, at the human 5-HT2B receptor by Rothman et al. (2000) , although other authors found lower affinity of this receptor.”
ResultBenfield, P., & Ward, A. (1986) · Drugs · doi:10.2165/00003495-198632040-00002 · Cited by 494
Videbech, P. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101001011.x · Cited by 419 · cited 1×
“Glucose metabolism in the brain is reduced in many regions, primarily in the frontotemporal parts, in patients suffering from unipolar depression (Little et al. 1996, 2005; Videbech 2000; Rasgon et al. 2008), with a correlation between the degree of hypometabolism and severity of the illness (Kimbrell et al. 2002) and…”
BackgroundPhospholipase A2 in the central nervous system
Sun, G. Y., Xu, J., Jensen, M. D., & Simonyi, A. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300016-jlr200 · Cited by 387 · cited 3×
“... observations confirm the observations by Qu et al. (2006), Rao et al. (2006), and Lee et al. (2008) who showed fluoxetine-mediated upregulation of cPLA2 activity and expression in intact brain by demonstrating similar cPLA2 upregulation by fluoxetine in astrocytes, a brain cell type that constitutes about 20% in g…”
BackgroundResultInfluentialBenfield, P., Heel, R. C., & Lewis, S. P. (1986) · Drugs · doi:10.2165/00003495-198632060-00002 · Cited by 335
A Natural Disruption of the Secretory Group II Phospholipase A2 Gene in Inbred Mouse Strains
Kennedy, B. P., Payette, P., Mudgett, J., Vadas, P., Pruzanski, W., Kwan, M., Tang, C., Rancourt, D. E., & Cromlish, W. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22378 · Cited by 325
Bonhaus, D. W., Bach, C., DeSouza, A., Salazar, F. H. R., Matsuoka, B. D., Zuppan, P., Chan, H. W., & Eglen, R. M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14977.x · Cited by 305
Setola, V., Hufeisen, S. J., Grande-Allen, K. J., Vesely, I., Glennon, R. A., Blough, B., Rothman, R. B., & Roth, B. L. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1223 · Cited by 304 · cited 1×
“its requirement for hyperlocomotion and 5-HT release induced by the "club drug" 3,4-methylenedioxymethamphetamine (MDMA), but this is supposed to be a presynaptic effect probably as an agonist of 5-HT2B receptors ( Setola et al. 2003 ), caused by reversal of the serotonin transporter and release of serotonin from sero…”
BackgroundEffect of sertraline on regional metabolic rate in patients with affective disorder
Buchsbaum, M. S., Joseph, W., Siegel, B. V., Hackett, E., Trenary, M., Abel, L., & Reynolds, C. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00097-2 · Cited by 303
Regional cerebral glucose utilization in patients with a range of severities of unipolar depression
Kimbrell, T. A., Ketter, T. A., George, M. S., Little, J. T., Benson, B. E., Willis, M. W., Herscovitch, P., & Post, R. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01216-1 · Cited by 301
Qi, X., Lin, W., Li, J., Li, H., Wang, W., Wang, D., & Sun, M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.003 · Cited by 249 · cited 1×
“They express 5-HT2 receptors (Hansson et al. 1987; Nilsson et al. 1991; Chen et al. 1995; Poblete and Azmitia 1995 ), including the more recently discovered 5-HT2B receptor (Sanden et al. 2000; Kong et al. 2002).”
BackgroundTiming of Onset of Antidepressant Response With Fluoxetine Treatment
Nierenberg, A. A., Farabaugh, A. H., Alpert, J. E., Gordon, J., Worthington, J. J., Rosenbaum, J. F., & Fava, M. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1423 · Cited by 248
Lipid Signaling in Neural Plasticity, Brain Repair, and Neuroprotection
Bazan, N. G. (2005) · Molecular Neurobiology · doi:10.1385/mn:32:1:089 · Cited by 236
The Effect of Paroxetine on 5-HT2A Receptors in Depression: An [18F]Setoperone PET Imaging Study
Meyer, J. H., Kapur, S., Eisfeld, B., Brown, G. M., Houle, S., DaSilva, J., Wilson, A. A., Rafi-Tari, S., Mayberg, H. S., & Kennedy, S. H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.1.78 · Cited by 231
Strokin, M., Sergeeva, M., & Reiser, G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705326 · Cited by 228 · cited 1×
“Release of arachidonic acid from astrocytes is stimulated by adenosine triphosphate ( Strokin et al. 2003 ), a "gliotransmitter" (Haydon and Carmignoto 2006), and may exert both autocrine and paracrine effects.”
BackgroundFelder, C. C., Kanterman, R. Y., Ma, A. L., & Axelrod, J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2187 · Cited by 220 · cited 1×
“After stimulation of one of several different neurotransmitter receptors, including 5-HT2A/2C receptors, cPLA2 releases arachidonic acid from the sn-2 position of membrane-bound phospholipid substrate in neural preparations ( Felder et al. 1990; Stout et al. 2002 ;Q u et al.2003; Rapoport 2008), including glioma cells…”
BackgroundHandbook of Neurochemistry: Volume 5 Metabolic Turnover in the Nervous System
(1983) · Springer eBooks · doi:10.1007/978-1-4899-4555-6 · Cited by 220
Bolo, N. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00116-0 · Cited by 202
Astrocyte calcium elevations: Properties, propagation, and effects on brain signaling
Fiacco, T. A., & McCarthy, K. D. (2006) · Glia · doi:10.1002/glia.20396 · Cited by 197 · cited 1×
“Astrocytes display receptors for a large number of transmitters (Hansson and Ronnback 2004; Fiacco and McCarthy 2006 ), including serotonin (Hertz et al. 1979).”
BackgroundBioenergetics of cerebral ischemia: A cellular perspective
Hertz, L. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.023 · Cited by 187 · cited 2×
“The present observations confirm the observations by Qu et al. (2006), Rao et al. (2006), and Lee et al. (2008) who showed fluoxetine-mediated upregulation of cPLA2 activity and expression in intact brain by demonstrating similar cPLA2 upregulation by fluoxetine in astrocytes, a brain cell type that constitutes about…”
BackgroundResultSelf-citationLiu, X., Smith, B. J., Chen, C., Callegari, E., Becker, S. L., Chen, X., Cianfrogna, J., Doran, A. C., Doran, S. D., Gibbs, J. P., et al. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079319 · Cited by 181
MAP Kinase Activation by Fluoxetine and Its Relation to Gene Expression in Cultured Rat Astrocytes
Mercier, G., Lennon, A. M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F., & Pierre, M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:2:207 · Cited by 176
Kursar, J. D., Nelson, D. L., Wainscott, D. B., & Baez, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09676-2 · Cited by 170
Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression
New, A. S., Buchsbaum, M. S., Hazlett, E. A., Goodman, M., Koenigsberg, H. W., Lo, J., Iskander, L., Newmark, R., Brand, J., O’Flynn, K., et al. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1913-8 · Cited by 169
Yu, A. C. H., Lee, Y. L., & Eng, L. F. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490340306 · Cited by 160 · cited 1×
“In primary cultures of astrocytes, exposure to arachidonic acid strongly stimulates both glucose metabolism ( Yu et al. 1993 ) and glycogenolysis (Sorg et al. 1995), and astrocytes account for ∼30% of glucose metabolism in the brain (reviewed by Hertz 2008).”
BackgroundActivation of Meningeal 5‐HT2B Receptors: An Early Step in the Generation of Migraine Headache?
Schmuck, K., Ullmer, C., Kalkman, H. O., Probst, A., & Lübbert, H. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01583.x · Cited by 154
Prostaglandin E2-synthesizing enzymes in fever: differential transcriptional regulation
Ivanov, A. I., Pero, R. S., Scheck, A. C., & Romanovsky, A. A. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00347.2002 · Cited by 152
Functional Studies in Cultured Astrocytes
Hertz, L., Peng, L., & Lai, J. C. K. (1998) · Methods · doi:10.1006/meth.1998.0686 · Cited by 151 · cited 1×
“Primary cultures of astrocytes were prepared as previously described ( Hertz et al. 1998 ) with minor modifications.”
MethodSelf-citationDoly, S., Valjent, E., Setola, V., Callebert, J., Hervé, D., Launay, J.-M., & Maroteaux, L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5723-07.2008 · Cited by 149 · cited 1×
“5-HT2B receptors are widespread in the human (Kursar et al. 1994; Baez et al. 1995; Bonhaus et al. 1995; Schmuck et al. 1996) and rodent ( Choi and Maroteaux 1996; Bonaventure et al. 2002) central nervous system, but their function is mainly unknown.”
BackgroundMatrix Metalloproteinase Inhibitors: A Structure−Activity Study
Levy, D. E., Lapierre, F., Liang, W., Ye, W., Lange, C. W., Li, X., Grobelny, D. W., Casabonne, M., Tyrrell, D. J., Holme, K. R., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970494j · Cited by 147
Choi, D.-S., & Maroteaux, L. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00695-3 · Cited by 146
Kong, E. K. C., Peng, L., Chen, Y., Yu, A. C., & Hertz, L. (2002) · Neurochemical Research · doi:10.1023/a:1014862808126 · Cited by 117 · cited 4×
“The RNA pellet was precipitated with isopropyl alcohol, washed with 70% ethyl alcohol, and dissolved in 10 µl sterile, distilled water and an aliquot was used for the determination of the amount of RNA ( Kong et al. 2002 ).”
BackgroundMethodInfluentialSelf-citationLi, B., Zhang, S., Zhang, H., Nu, W., Cai, L., Hertz, L., & Peng, L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1306-5 · Cited by 115
Self-citationLittle, J. T., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Benson, B. E., Willis, M. W., Luckenbaugh, D. A., & Post, R. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.033 · Cited by 104
Non-Neuronal Cells of the Nervous System: Function and Dysfunction
(2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(00)x9001-7 · Cited by 104
Balboa, M. A., & Balsinde, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206155200 · Cited by 103
Garcia, M. C., & Kim, H. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00583-0 · Cited by 101 · cited 2×
“After stimulation of one of several different neurotransmitter receptors, including 5-HT2A/2C receptors, cPLA2 releases arachidonic acid from the sn-2 position of membrane-bound phospholipid substrate in neural preparations (Felder et al. 1990; Stout et al. 2002 ;Q u et al.2003; Rapoport 2008), including glioma cells…”
BackgroundResultHenry, M., Schmidt, M. E., Hennen, J. A., Villafuerte, R. A., Butman, M. L., Tran, P., Kerner, L. T., Cohen, B. M., & Renshaw, P. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300749 · Cited by 93
Rapoport, S. I. (2008) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.010 · Cited by 91 · cited 1×
“After stimulation of one of several different neurotransmitter receptors, including 5-HT2A/2C receptors, cPLA2 releases arachidonic acid from the sn-2 position of membrane-bound phospholipid substrate in neural preparations (Felder et al. 1990; Stout et al. 2002 ;Q u et al.2003; Rapoport 2008 ), including glioma cells…”
BackgroundBonaventure, P., Nepomuceno, D. H., Kwok, A. K., Chai, W., Langlois, X., Hen, R., Stark, K. L., Carruthers, N. I., & Lovenberg, T. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.240 · Cited by 87
Mårtensson, B., Nyberg, S., Toresson, G., Brodin, E., & Bertilsson, L. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb10307.x · Cited by 86 · cited 1×
“However, both compounds are heavily proteinbound, and in the cerebrospinal fluid, the concentration is at least ten times lower ( Martensson et al. 1989; Liu et al. 2005).”
BackgroundPharmacological characterisation of human 5-HT2 receptor subtypes
Jerman, J. C., Brough, S. J., Gager, T., Wood, M. D., Coldwell, M. C., Smart, D., & Middlemiss, D. N. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00775-0 · Cited by 86
Distribution of cytoplasmic phospholipase A2 in the normal rat brain.
Ong, W. Y., Tl, S., Horrocks, L. A., & Farooqui, A. A. (1999) · PubMed · Cited by 71
Hansson, E., Simonsson, P., & Alling, C. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90102-x · Cited by 69 · cited 1×
“They express 5-HT2 receptors ( Hansson et al. 1987; Nilsson et al. 1991; Chen et al. 1995; Poblete and Azmitia 1995), including the more recently discovered 5-HT2B receptor (Sanden et al. 2000; Kong et al. 2002).”
BackgroundMolecular Biology of Serotonin Receptors
Baez, M., Kursar, J. D., Helton, L. A., Wainscott, D. B., & Nelson, D. L. G. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00211.x · Cited by 69
Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells
Chen, Y., Peng, L., Zhang, X., Stolzenburg, J., & Hertz, L. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00082-p · Cited by 68 · cited 1×
“They express 5-HT2 receptors (Hansson et al. 1987; Nilsson et al. 1991; Chen et al. 1995; Poblete and Azmitia 1995), including the more recently discovered 5-HT2B receptor (Sanden et al. 2000; Kong et al. 2002).”
BackgroundSelf-citationRapid Desensitization of the Serotonin2C Receptor System: Effector Pathway and Agonist Dependence
Stout, B. D., Clarke, W. P., & Berg, K. A. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.3.957 · Cited by 67 · cited 1×
“After stimulation of one of several different neurotransmitter receptors, including 5-HT2A/2C receptors, cPLA2 releases arachidonic acid from the sn-2 position of membrane-bound phospholipid substrate in neural preparations (Felder et al. 1990; Stout et al. 2002 ; Q u et al.2003; Rapoport 2008), including glioma cells…”
BackgroundSerotonin receptors on astrocytes in primary cultures: Effects of methysergide and fluoxetine
Hertz, L., Baldwin, F., & Schousboe, A. (1979) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y79-034 · Cited by 66
Self-citationPlasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression
Elizabeth Sublette, M., Milak, M. S., Hibbeln, J. R., Freed, P. J., Oquendo, M. A., Malone, K. M., Parsey, R. V., & John Mann, J. (2009) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.11.004 · Cited by 65
Sandén, N., Thorlin, T., Blomstrand, F., Persson, A. I., & Hansson, E. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00134-5 · Cited by 61 · cited 1×
“They express 5-HT2 receptors (Hansson et al. 1987; Nilsson et al. 1991; Chen et al. 1995; Poblete and Azmitia 1995), including the more recently discovered 5-HT2B receptor ( Sanden et al. 2000; Kong et al. 2002).”
BackgroundPotassium‐stimulated calcium uptake in astrocytes and its potent inhibition by nimodipine
Hertz, L., Bender, A. S., Woodbury, D. M., & White, H. S. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490220215 · Cited by 61
Self-citationYu, P. H., & Hertz, L. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb12598.x · Cited by 59 · cited 1×
“Since these cultures express no serotonin transporter (Kong et al. 2002; Li and Peng, unpublished experiments) and any 5-HT present in the serum added to the culturing medium is rapidly metabolized by the high monooxidase activity in the cells ( Yu and Hertz 1982, 1983 ), the upregulation cannot be caused by inhibitio…”
BackgroundSelf-citationMilak, M. S., Parsey, R. V., Lee, L., Oquendo, M. A., Olvet, D. M., Eipper, F., Malone, K., & Mann, J. J. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2008.09.004 · Cited by 58
Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin?
Beyer, C. E., & Cremers, T. I. F. H. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.028 · Cited by 57 · cited 1×
“During chronic administration of an SSRI, the 5-HT levels in the brain become increased, at least in most regions ( Beyer and Cremers 2008 ), long before amelioration of mood (Nierenberg et al. 2000), suggesting that changes in signaling in response to either the increased extracellular 5-HT concentration, or perhaps…”
BackgroundNilsson, M., Hansson, E., & Rönnbäck, L. (1991) · Developmental Brain Research · doi:10.1016/0165-3806(91)90064-p · Cited by 53 · cited 1×
“They express 5-HT2 receptors (Hansson et al. 1987; Nilsson et al. 1991; Chen et al. 1995; Poblete and Azmitia 1995), including the more recently discovered 5-HT2B receptor (Sanden et al. 2000; Kong et al. 2002).”
BackgroundLi, B., Du, T., Li, H., Gu, L., Zhang, H., Huang, J., Hertz, L., & Peng, L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.58 · Cited by 52
Self-citationPoblete, J. C., & Azmitia, E. C. (1995) · Brain Research · doi:10.1016/0006-8993(95)00201-z · Cited by 51
Lee, H., Rao, J. S., Chang, L., Rapoport, S. I., & Bazinet, R. P. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700406-jlr200 · Cited by 47 · cited 3×
“The present observations confirm the observations by Qu et al. (2006), Rao et al. (2006), and Lee et al. (2008) who showed fluoxetine-mediated upregulation of cPLA2 activity and expression in intact brain by demonstrating similar cPLA2 upregulation by fluoxetine in astrocytes, a brain cell type that constitutes about…”
BackgroundResultInfluentialSorg, O., Pellerin, L., Stolz, M., Beggah, S., & Magistretti, P. J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11410-x · Cited by 46 · cited 1×
“In primary cultures of astrocytes, exposure to arachidonic acid strongly stimulates both glucose metabolism (Yu et al. 1993) and glycogenolysis ( Sorg et al. 1995 ), and astrocytes account for ∼30% of glucose metabolism in the brain (reviewed by Hertz 2008).”
BackgroundLittle, J. T., Ketter, T. A., Kimbrell, T. A., Danielson, A., Benson, B., Willis, M. W., & Post, R. M. (1996) · PubMed · Cited by 45
Co-localization of cytosolic phospholipase A2 and cyclooxygenase-2 in Rhesus monkey cerebellum
Pardue, S., Rapoport, S. I., & Bosetti, F. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00262-6 · Cited by 45 · cited 1×
“In the brain in vivo, the majority of cPLA2 expression in gray matter may be in astrocytes (Lautens et al. 1998; Balboa and Balsinde 2002; Sun et al. 2004), although a predominantly neuronal expression was reported by Ong et al. (1999) and Pardue et al. (2003) .”
BackgroundTay, A., Maxwell, A. P., Li, Z. G., Goldberg, H., & Skorecki, K. L. (1994) · Biochemical Journal · doi:10.1042/bj3040417 · Cited by 40
Pharmacokinetics of Fluoxetine in Elderly Men and Women
Ferguson, J. M., & Hill, H. (2006) · Gerontology · doi:10.1159/000089825 · Cited by 35 · cited 3×
“The present observations confirm the observations by Qu et al. (2006), Rao et al. (2006), and Lee et al. (2008) who showed fluoxetine-mediated upregulation of cPLA2 activity and expression in intact brain by demonstrating similar cPLA2 upregulation by fluoxetine in astrocytes, a brain cell type that constitutes about…”
BackgroundResultInfluentialQu, Y., Chang, L., Klaff, J., Seemann, R., & Rapoport, S. I. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300177 · Cited by 35
Marjou, M., Montalescot, V., Buzyn, A., & Geny, B. (2000) · Leukemia · doi:10.1038/sj.leu.2401958 · Cited by 31
Astrocytic receptors and second messenger systems
Hansson, E., & Rönnbäck, L. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31021-5 · Cited by 31 · cited 1×
“Astrocytes display receptors for a large number of transmitters ( Hansson and Ronnback 2004; Fiacco and McCarthy 2006), including serotonin (Hertz et al. 1979).”
BackgroundZhao, Z., Hertz, L., & Code, W. E. (1996) · PubMed · Cited by 29
Self-citationZhao, Z., Hertz, L., & Code, W. E. (1996) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y96-012 · Cited by 29
Self-citationLautens, L. L., Chiou, X. G., Sharp, J., Young, W. S., Sprague, D. L., Ross, L. S., & Felder, C. C. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00806-3 · Cited by 27
Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized rats
Qu, Y., Chang, L., Klaff, J., Seemann, R., GREENSTEIN, D. K., & Rapoport, S. I. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.01.008 · Cited by 24 · cited 2×
“In an attempt to clarify such mechanisms, Rapoport and coworkers ( Qu et al. 2006; Rao et al. 2006; Lee et al. 2008) recently showed that chronic administration of fluoxetine (10 mg/kg/day) for 21 days leads to stimulation and enhanced mRNA and protein expression of Ca 2+ -depen-”
BackgroundResultLi, B., Gu, L., Zhang, H., Huang, J., Chen, Y., Hertz, L., & Peng, L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0853-5 · Cited by 24 · cited 1×
“The transactivation is inhibited by GM6001, a metalloproteinase inhibitor (Levy et al. 1998), and by AG1478, an inhibitor of the receptor tyrosine kinase of the EGF receptor ( Levitzki and Gazit 1995 ).”
BackgroundSelf-citationCerebral metabolic patterns in untreated postmenopausal women with major depressive disorder
Rasgon, N., Kenna, H. A., Geist, C. L., Small, G. W., & Silverman, D. H. S. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.12.006 · Cited by 23 · cited 1×
“Glucose metabolism in the brain is reduced in many regions, primarily in the frontotemporal parts, in patients suffering from unipolar depression (Little et al. 1996, 2005; Videbech 2000; Rasgon et al. 2008 ), with a correlation between the degree of hypometabolism and severity of the illness (Kimbrell et al. 2002) an…”
BackgroundExpression of members of the phospholipase A2family of enzymes in human nasal mucosa
Lindbom, J., Ljungman, A. G., Lindahl, M., & Tagesson, C. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00054701 · Cited by 23 · cited 1×
“and 0.2 µM of sense or antisense for cPLA2a (forward, GCACATTATAGTGGAACACC; reverse, ACACAGTGC CATGCTGAACC) (Ivanov et al. 2002); iPLA2 (forward, ACCTAGCCGTGGAGCTTGG; reverse, GCCCTTGG TTGTTTACCTGG) ( Lindbom et al. 2001 ); sPLA2 (forward, AGCTGACAGCATGAAGGTCCTCC; reverse, TTCTGGGTGAAGACAGAAGGGCC; Kennedy et al. 1995)…”
MethodInfluentialType a and b monoamine oxidase in glial cells in long-term culture
Yu, P. H., & Hertz, L. (1983) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(83)90046-5 · Cited by 13 · cited 1×
“Since these cultures express no serotonin transporter (Kong et al. 2002; Li and Peng, unpublished experiments) and any 5-HT present in the serum added to the culturing medium is rapidly metabolized by the high monooxidase activity in the cells ( Yu and Hertz 1982, 1983 ), the upregulation cannot be caused by inhibitio…”
BackgroundSelf-citation
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“61 In addition, the increased expression of cFos induced by fl uoxetine can further increases the RNA editing of GluK2 by increasing the expression of ADAR2 at the chronic treatments, the function of the edited GluK2 by fl uoxetine is down-regulated, which causes the acute glutamated induced Ca 2 +…”
BackgroundSelf-citationCobb, J. A., O’Neill, K., Milner, J., Mahajan, G. J., Lawrence, T. J., May, W. L., Miguel-Hidalgo, J., Rajkowska, G., & Stockmeier, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.044 · Cited by 254
“Treatments effective in MDD promote astrocyte proliferation and gene expression (Fujiki and Steward, 1997; Jansson et al., 2009; Li et al., 2009; Liu et al., 2009), whereas a glial toxin-induced reduction of the astrocyte population in medial prefrontal cortex induces a depressive-like phenotype in…”
BackgroundSerotonergic signaling: multiple effectors and pleiotropic effects
Masson, J., Emerit, M. B., Hamon, M., & Darmon, M. C. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.50 · Cited by 151
Antidepressants act directly on astrocytes: Evidences and functional consequences
Czéh, B., & Benedetto, B. D. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.017 · Cited by 144
Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo
Kaddurah-Daouk, R., Bogdanov, M. B., Wikoff, W. R., Zhu, H., Boyle, S. H., Churchill, E., Wang, Z., Rush, A. J., Krishnan, R. R., Pickering, E., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.142 · Cited by 101
“calcium-dependent phospholipase A2 (PLA2), which releases arachidonic acid from the membrane-bound phospholipids.(44,45) Additional mechanism, involving PLA2 activation”
Background
Metadata
- Authors
- Li, B., Zhang, S., Li, M., Hertz, L., & Peng, L.
- Affiliations
- China Medical University (CN)
- Corresponding author
- Peng, Liang
- Venue
- Psychopharmacology
- Published
- 2009-08-07
- Volume
- 207
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2068783760
- Cited by
- 52
- References
- 81
- Citations by year
- 2026: 2 · 2024: 1 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 3 · 2015: 7 · 2014: 2 · 2013: 6 · 2012: 7
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- fluoxetine, 5-HT2B receptor, astrocytes, cytosolic phospholipase A2, ERK1/2 phosphorylation, transcriptional activation, EGF receptor signaling, arachidonic acid, serotonin, selective serotonin reuptake inhibitors, major depressive disorder, brain glucose metabolism, chronic drug administration, antidepressant mechanism, neuroinflammation
- MeSH terms
- Animals, Astrocytes, Cells, Cultured, Cerebral Cortex, Dose-Response Relationship, Drug, Enzyme Inhibitors, Fluoxetine, Gene Expression Regulation, Indoles, Phosphorylation, RNA, Messenger, Time Factors, Urea, Selective Serotonin Reuptake Inhibitors, Mitogen-Activated Protein Kinase 1, Receptor, Serotonin, 5-HT2B, Mitogen-Activated Protein Kinase 3, Mice, Phospholipases A2, Serotonin 5-HT2 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.